Related Information

Information on collection of data, the provided financial cost and defined daily doses.    

Information on supplies of drugs to healthcare institutions, pharmacies and sellers of restricted drugs

(Section 23 (1) (d) of the Act on Drugs)

The information on quantities of medicines going through the distribution chain was acquired by integration of monthly reports by entities authorised to distribute medicines in the CzechRepublic. The subject of reports includes supplies of medicines from distributors and end producers (distribution of medicines produced by the producer) to pharmacies, other healthcare facilities and veterinarians authorised to perform specialised veterinary activity.

Following the reduction of the reporting interval, the report is newly broken down to the report on supplies and the report on returns (the report b the distributor separately provides information on supplies of medicines and information on returns of medicines from pharmacies).

The report includes supplies to other distributors and reports on supplies to foreign customers.

The information presented in this article is related to medicines that may be put into circulation in the Czech Republic based on a valid registration with the State Institute for Drug Control or a registration approved by approved centralised procedure of the EU, to medicines for which the so-called specific treatment programs were approved, and to unregistered medicines supplied to a specific patient based on a medical prescription.

As of 1 January, 2012, the published outputs do not include food for special medical purposes (FSMP).

Information acquired from reports on dispensed medicines from operators authorised to dispense

(Section 82 (3)  (d), Act on Drugs)

The information of volumes of dispensed medicines were acquired by integration of monthly reports by operators authorised to dispense drugs in theCzech Republic. The subject of reports includes medicines dispensed based on a medical prescription or without a medical prescription with the restriction monitored by SUKL pursuant to the instruction LEK-13, the current version, within monitoring of consumption of medicines in ČR.

The information presented in this article relates to medicines registered by the State Institute for Drug Control or by the European Commission. Also to unregistered medicines, for which the so-called specific treatment programs were approved, or to medicines dispensed based on a medical prescription for a specific patient.

Financial cost

Taking into account the need for comparison of financial volumes of medicines going through the distribution chain during the years, there is a change as of the year 2010 and the article uses information about financial volumes of medicines based exclusively on the production prices announced by distributors and producers (i.e. the information on financial cost does not include VAT and the sales margin).

The State Institute for Drug Control thus discontinues evaluation of financial cost based on the financial volumes calculated from the end consumer price, due to the changing VAT rate and sales margin during the years. The resulting data did not represent actual cost of medicines, but the maximum possible cost which could have been significantly overvalued compared to the actual situation.

Defined daily doses

Monitoring of trends in supplies of medicines uses comparisons of distributed volumes of the number of packages, financial indicators and defined daily doses (hereinafter as “DDD”) by quarters in the last five years.

The currently valid values of DDD are available on the website WHO Collaborating Centre for Drug Statistics Methodology - http://www.whocc.no/.

The conversion of DDD to 1,000 inhabitants may use the number of inhabitants of ČR for the respective calendar year acquired from the data of the Czech Statistical Office. For 2012, the number as of 31 December, 2011 is 10,504,203 inhabitants.